Professor of Medicine, College of Medicine and Science Center for Individualized Medicine at the Mayo Clinic
Konstantinos N. Lazaridis, M.D., is considered a leader in the area of the genomics of chronic cholestatic liver diseases, namely, Primary Biliary Cholangitis (PBC) and Primary Sclerosing Cholangitis (PSC). Since 2003, he has established and is the principal investigator of the two national consortia for studying patients afflicted with these diseases. His research group applies the latest genomic and exposomic approaches to better understand the pathogenesis as well as outcomes and improve the therapy of patients with PBC and PSC. These research efforts are supported by the NIH. He was elected to the American Society of Clinical Investigation (ASCI) in 2015. As the Everett J. and Jane M. Hauck Associate Director for the Center for Individualized Medicine at Mayo Clinic, Dr. Lazaridis has been instrumental in establishing the Individualized Medicine Clinic and in integrating the latest genomic discoveries into clinical services. Dr. Lazaridis received his medical degree at the University of Ioannina in Greece. He completed his Internal Medicine and Gastroenterology fellowship training at Mayo Clinic and was a Mayo Clinic Scholar in Genomics in the laboratory of Dr. Francis Collins at the National Human Genome Research Institute.
Also Available On Demand.
How can we take steps toward more personalized care of patients living with primary sclerosing cholangitis (PSC)? This intriguing lecture will provide an overview of the latest knowledge on the PSC pathogenesis. Faculty will then expand the discussion to cover potential applications of these advances in the clinic to improve and individualize care of patients with PSC.